Cullinan Associates Inc Eli Lilly & CO Transaction History

Cullinan Associates Inc

$1.75 Billion
Q2 2024

A detailed history of Cullinan Associates Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Cullinan Associates Inc holds 9,283 shares of LLY stock, worth $8.22 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

9,283

Previous 6,628 40.06%

Holding current value

$8.22 Million

Previous $5.16 Million 62.99%

% of portfolio

0.48%

Previous 0.29%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 10, 2024	BUY	$724.87 - $909.04 $1.92 Million - $2.41 Million	2,655 Added 40.06%	9,283 $8.4 Million
Q1 2024 Apr 18, 2024	BUY	$592.2 - $792.28 $182,989 - $244,814	309 Added 4.89%	6,628 $5.16 Million
Q4 2023 Jan 24, 2024	SELL	$525.19 - $619.13 $553,550 - $652,563	-1,054 Reduced 14.3%	6,319 $3.68 Million
Q3 2023 Oct 11, 2023	BUY	$434.7 - $599.3 $580,324 - $800,065	1,335 Added 22.11%	7,373 $3.96 Million
Q2 2023 Jul 14, 2023	SELL	$350.74 - $468.98 $35,074 - $46,898	-100 Reduced 1.63%	6,038 $2.83 Million
Q1 2023 Apr 05, 2023	SELL	$310.63 - $364.82 $155,315 - $182,410	-500 Reduced 7.53%	6,138 $2.11 Million
Q4 2022 Jan 11, 2023	BUY	$321.55 - $374.67 $783,938 - $913,445	2,438 Added 58.05%	6,638 $2.43 Million
Q3 2022 Oct 19, 2022	BUY	$296.48 - $337.87 $711,552 - $810,888	2,400 Added 133.33%	4,200 $1.36 Million
Q2 2022 Jul 08, 2022	BUY	$278.73 - $327.27 $167,238 - $196,362	600 Added 50.0%	1,800 $584,000
Q4 2021 Jan 07, 2022	SELL	$224.85 - $279.04 $112,425 - $139,520	-500 Reduced 29.41%	1,200 $331,000
Q3 2021 Oct 08, 2021	SELL	$221.6 - $272.71 $221,600 - $272,710	-1,000 Reduced 37.04%	1,700 $393,000
Q2 2021 Jul 07, 2021	SELL	$180.55 - $233.54 $31,776 - $41,103	-176 Reduced 6.12%	2,700 $620,000
Q1 2021 Apr 20, 2021	SELL	$164.32 - $212.72 $3.24 Million - $4.19 Million	-19,700 Reduced 87.26%	2,876 $537,000
Q4 2020 Jan 14, 2021	SELL	$130.46 - $172.63 $6,392 - $8,458	-49 Reduced 0.22%	22,576 $3.81 Million
Q3 2020 Oct 09, 2020	SELL	$146.22 - $169.13 $848,076 - $980,954	-5,800 Reduced 20.4%	22,625 $3.35 Million
Q2 2020 Jul 07, 2020	SELL	$136.42 - $164.18 $341,049 - $410,450	-2,500 Reduced 8.08%	28,425 $4.67 Million
Q1 2020 Apr 01, 2020	SELL	$119.05 - $147.35 $916,685 - $1.13 Million	-7,700 Reduced 19.94%	30,925 $4.29 Million
Q4 2019 Jan 15, 2020	BUY	$106.92 - $132.43 $181,764 - $225,131	1,700 Added 4.6%	38,625 $5.08 Million
Q3 2019 Oct 01, 2019	SELL	$106.79 - $116.16 $10,679 - $11,616	-100 Reduced 0.27%	36,925 $4.13 Million
Q2 2019 Jul 16, 2019	BUY	$110.79 - $129.32 $11,079 - $12,932	100 Added 0.27%	37,025 $4.1 Million
Q1 2019 Apr 30, 2019	SELL	$111.31 - $131.02 $1.52 Million - $1.79 Million	-13,700 Reduced 27.06%	36,925 $4.79 Million
Q4 2018 Jan 11, 2019	SELL	$105.9 - $118.64 $279,787 - $313,446	-2,642 Reduced 4.96%	50,625 $5.86 Million
Q3 2018 Oct 19, 2018	BUY	$85.86 - $107.31 $1.63 Million - $2.04 Million	19,000 Added 55.45%	53,267 $5.72 Million
Q2 2018 Jul 09, 2018	SELL	$75.7 - $86.88 $37,850 - $43,440	-500 Reduced 1.44%	34,267 $2.92 Million
Q1 2018 Apr 27, 2018	BUY	$74.21 - $87.6 $14,841 - $17,520	200 Added 0.58%	34,767 $2.69 Million
Q4 2017 Jan 17, 2018	BUY	$81.94 - $87.89 $106,522 - $114,257	1,300 Added 3.91%	34,567 $2.92 Million
Q3 2017 Oct 16, 2017	BUY	$77.07 - $85.54 $2.56 Million - $2.85 Million	33,267	33,267 $2.85 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $842B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullinan Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cullinan Associates Inc with notifications on news.

Account

Cullinan Associates Inc Eli Lilly & CO Transaction History